140 related articles for article (PubMed ID: 38615659)
1. Metabolic Syndrome and Cardiac Vessel Remodeling Associated with Vessel Rarefaction: A Possible Underlying Mechanism May Result from a Poor Angiogenic Response to Altered VEGF Signaling Pathways.
Bartkowiak K; Bartkowiak M; Jankowska-Steifer E; Ratajska A; Kujawa M; Aniołek O; Niderla-Bielińska J
J Vasc Res; 2024 Apr; ():1-9. PubMed ID: 38615659
[TBL] [Abstract][Full Text] [Related]
2. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling.
Kivelä R; Hemanthakumar KA; Vaparanta K; Robciuc M; Izumiya Y; Kidoya H; Takakura N; Peng X; Sawyer DB; Elenius K; Walsh K; Alitalo K
Circulation; 2019 May; 139(22):2570-2584. PubMed ID: 30922063
[TBL] [Abstract][Full Text] [Related]
4. Mitoprotection attenuates myocardial vascular impairment in porcine metabolic syndrome.
Yuan F; Hedayat AF; Ferguson CM; Lerman A; Lerman LO; Eirin A
Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H669-H680. PubMed ID: 29196345
[TBL] [Abstract][Full Text] [Related]
5. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance.
Wada H; Satoh N; Kitaoka S; Ono K; Morimoto T; Kawamura T; Nakano T; Fujita M; Kita T; Shimatsu A; Hasegawa K
Atherosclerosis; 2010 Feb; 208(2):512-7. PubMed ID: 19695569
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and cell-specific genetic PI3Kα inhibition worsens cardiac remodeling after myocardial infarction.
Chen X; Zhabyeyev P; Azad AK; Vanhaesebroeck B; Grueter CE; Murray AG; Kassiri Z; Oudit GY
J Mol Cell Cardiol; 2021 Aug; 157():17-30. PubMed ID: 33887328
[TBL] [Abstract][Full Text] [Related]
7. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
[TBL] [Abstract][Full Text] [Related]
8. VEGF-B Promotes Endocardium-Derived Coronary Vessel Development and Cardiac Regeneration.
Räsänen M; Sultan I; Paech J; Hemanthakumar KA; Yu W; He L; Tang J; Sun Y; Hlushchuk R; Huan X; Armstrong E; Khoma OZ; Mervaala E; Djonov V; Betsholtz C; Zhou B; Kivelä R; Alitalo K
Circulation; 2021 Jan; 143(1):65-77. PubMed ID: 33203221
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Endothelial Notch Signaling Impairs Fatty Acid Transport and Leads to Metabolic and Vascular Remodeling of the Adult Heart.
Jabs M; Rose AJ; Lehmann LH; Taylor J; Moll I; Sijmonsma TP; Herberich SE; Sauer SW; Poschet G; Federico G; Mogler C; Weis EM; Augustin HG; Yan M; Gretz N; Schmid RM; Adams RH; Gröne HJ; Hell R; Okun JG; Backs J; Nawroth PP; Herzig S; Fischer A
Circulation; 2018 Jun; 137(24):2592-2608. PubMed ID: 29353241
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells.
Albrecht-Schgoer K; Schgoer W; Holfeld J; Theurl M; Wiedemann D; Steger C; Gupta R; Semsroth S; Fischer-Colbrie R; Beer AG; Stanzl U; Huber E; Misener S; Dejaco D; Kishore R; Pachinger O; Grimm M; Bonaros N; Kirchmair R
Circulation; 2012 Nov; 126(21):2491-501. PubMed ID: 23081990
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
[TBL] [Abstract][Full Text] [Related]
12. The life cycle of a capillary: Mechanisms of angiogenesis and rarefaction in microvascular physiology and pathologies.
Manning D; Rivera EJ; Santana LF
Vascul Pharmacol; 2024 Jun; 156():107393. PubMed ID: 38857638
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
Salven P; Hattori K; Heissig B; Rafii S
FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
[TBL] [Abstract][Full Text] [Related]
14. Endothelial specific SIRT3 deletion impairs glycolysis and angiogenesis and causes diastolic dysfunction.
He X; Zeng H; Chen ST; Roman RJ; Aschner JL; Didion S; Chen JX
J Mol Cell Cardiol; 2017 Nov; 112():104-113. PubMed ID: 28935506
[TBL] [Abstract][Full Text] [Related]
15. Loss of Endothelial CXCR7 Impairs Vascular Homeostasis and Cardiac Remodeling After Myocardial Infarction: Implications for Cardiovascular Drug Discovery.
Hao H; Hu S; Chen H; Bu D; Zhu L; Xu C; Chu F; Huo X; Tang Y; Sun X; Ding BS; Liu DP; Hu S; Wang M
Circulation; 2017 Mar; 135(13):1253-1264. PubMed ID: 28154007
[TBL] [Abstract][Full Text] [Related]
16. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.
Brudno Y; Ennett-Shepard AB; Chen RR; Aizenberg M; Mooney DJ
Biomaterials; 2013 Dec; 34(36):9201-9. PubMed ID: 23972477
[TBL] [Abstract][Full Text] [Related]
17. Cardiac epigenetic changes in VEGF signaling genes associate with myocardial microvascular rarefaction in experimental chronic kidney disease.
Eirin A; Chade AR
Am J Physiol Heart Circ Physiol; 2023 Jan; 324(1):H14-H25. PubMed ID: 36367693
[TBL] [Abstract][Full Text] [Related]
18. Spatial-temporal order-disorder transition in angiogenic NOTCH signaling controls cell fate specification.
Kang TY; Bocci F; Nie Q; Onuchic JN; Levchenko A
Elife; 2024 Feb; 12():. PubMed ID: 38376371
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell mineralocorticoid receptors oppose VEGF-induced gene expression and angiogenesis.
Lother A; Deng L; Huck M; Fürst D; Kowalski J; Esser JS; Moser M; Bode C; Hein L
J Endocrinol; 2019 Jan; 240(1):15-26. PubMed ID: 30400069
[TBL] [Abstract][Full Text] [Related]
20. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.
Winter MP; Sharma S; Altmann J; Seidl V; Panzenböck A; Alimohammadi A; Zelniker T; Redwan B; Nagel F; Santer D; Stieglbauer A; Podesser B; Sibilia M; Helbich T; Prager G; Ilhan-Mutlu A; Preusser M; Lang IM
Basic Res Cardiol; 2020 Sep; 115(6):58. PubMed ID: 32880713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
